Agilent Technologies, Inc. (A) – Improving Margins as strategic initiative

Agilent Technologies, Inc. (A) (Q3FY23)

Stock Performance – Agilent Technologies’ stock price showed a downward trend in past 3-months. It declined by 5.44% during the period. The price declined by 13.18% in past 1-year. It has a 52-week high of $160.26 and its 52-week low is $108.77.

In the past 3 years, the stock has given returns of 4.61%. Agilent has a 50-day moving Avg. and 200-day moving Avg. of $117.88 and $131.12, respectively.

Revenue Performance – Net revenue of $1,672mn and $5,145mn for the three and nine months ended July 31, 2023 decreased 3% and increased 3%, respectively, when compared to the same periods last year. Foreign currency movements for the three and nine months ended July 31, 2023 had an overall unfavorable impact on revenue growth of 1 percentage point and 3 percentage points, respectively, when compared to the same periods last year.

Company Guidance for FY23 – Agilent expects revenue to be in the range of $6.80bn to $6.85bn, representing a decline of 0.7% to flat reported growth, and a core growth range representing an increase of 0.8% to 1.5% year-over-year.

Highlights

Agilent’s operates in the Diagnostic and Research sector with its close competitors like, Thermo Fisher Scientific Inc., and Danaher Corporation. Recently this industry is characterised by the use of artificial intelligence and machine learning.

This report is useful for M&A, business & investment analysis to all students, researchers, investors, private equity houses, broking firms, hedge funds, advisory firms and corporates to decide upon their investment strategies. Do connect with us, if you are looking for equity valuation, recommendation, analysis and market recommendation for any specific company, sector and industry.

Highlights

Valuation

– Enterprise Value
– CrispIdea Forecast
– CrispIdea Segment Forecast
– Economic Value Added Analysis
– Discounted Cash Flow Analysis
– PE Band Comparison
– Peer Valuation
– CrispIdea Forecast Relative to Consensus
– Consensus History and Surprise
– Consensus Momentum

Actual & Historical Performance

– Income Statement
– Balance Sheet
– Cash Flow
– 10 Year Historical Performance
– Ratio Analysis
– Du Pont Analysis
– ROIC & ROCE Analysis
– Segment Performance
– M&A Deals

Peer Performance

– Summary
– Profitability
– Growth
– Price Performance

Ownership

Stock Price Performance

Crispidea Coverage

No of Pages: 34

To download the previous quarter’s equity/report CLICK HERE

To Download other equity/reports CLICK HERE

Follow our LinkedIn page for more updates.